| Literature DB >> 30987200 |
Ángela Hernández-Ruiz1,2, Belén García-Villanova3, Eduardo Guerra-Hernández4, Pilar Amiano5,6, Miguel Ruiz-Canela7,8,9, Esther Molina-Montes10,11.
Abstract
Oxidative Balance Scores (OBSs) are tools that have emerged to evaluate the global balance of individuals' oxidation-reduction status. The aim was to compare OBSs available in the literature regarding their characteristics and associations with chronic diseases in epidemiological studies. Studies that developed OBSs were searched in PubMed until August 2018. A total of 21 OBSs were identified. These OBSs presented different scoring schemes and different types of anti- and pro-oxidant components, including dietary factors (dietary intake and/or nutrient biomarkers), lifestyle factors, and medications. Most OBSs were based on over 10 components, and some included only dietary factors. Few considered weighted components in the score. Only three OBSs were validated as potential surrogates of oxidative balance through inflammation and OS-related biomarkers. Notably, all the OBSs were associated-to a varying degree-with a reduced risk of cardiovascular diseases, chronic kidney disease, colorectal adenomas, and different cancer types (colorectal and breast cancer), as well as with all-cause and cancer-related mortality. For other outcomes, e.g., prostate cancer, contradictory results were reported. In summary, there is a great heterogeneity in the definition of OBSs. Most studies are concordant in supporting that excessive OS reflected by a lower OBS has deleterious effects on health. Unified criteria for defining the proper OBSs, valuable to gauge OS-related aspects of the diet and lifestyle that may lead to adverse health outcomes, are needed.Entities:
Keywords: antioxidants; healthy diet; healthy lifestyle; oxidative stress; review
Mesh:
Substances:
Year: 2019 PMID: 30987200 PMCID: PMC6520884 DOI: 10.3390/nu11040774
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Description of the a priori Oxidative Balance Scores (OBSs), components, and scoring systems.
| Author (s), Year | OBSs Components | Type of Components | Scoring per Component | Score Range | |
|---|---|---|---|---|---|
| Van Hoydonck et al., 2002 [ | 3 | 2 Antioxidant/ | Dietary | 1–3 | 3–9 |
| Goodman et al., 2007 [ | 12 | 9 Antioxidant/ | Dietary, biomarkers, lifestyle and medication | 0–1 | 0–12 |
| Goodman et al., 2008 [ | 12 | 8 Antioxidant/ | Dietary, lifestyle and medication | 0–2 | 0–24 |
| Goodman et al., 2010 [ | 14 | 11 Antioxidant/ | Dietary, biomarkers, lifestyle and medication | 0–2 | 0–28 |
| Agalliu et al., 2011 [ | 13 | 8 Antioxidant/ | Dietary and lifestyle | 0–4 | 0–52 |
| Slattery et al., 2012 [ | 13 | 10 Antioxidant/ | Dietary, lifestyle and medication | 0–2 | 0–26 |
| Geybels et al., 2012 [ | 8 | 5 Antioxidant/ | Dietary and lifestyle | 0–3 | 0–24 |
| Dash et al., 2013 [ | 15 | 9 Antioxidant/ | Dietary and lifestyle | −1–1 | −6–9 |
| Labadie et al., 2013 [ | 11 | 7 Antioxidant/ | Dietary, lifestyle and medication | 0–2 | 0–22 |
| Kong et al., 2014 [ | 14 | 10 Antioxidant/ | Dietary, biomarkers, lifestyle and medication | 0–2 | 0–28 |
| Slattery et al., 2014 [ | 6 | 5 Antioxidant/ | Dietary | 0–2 | 0–12 |
| Lakkur et al., 2014a [ | 20 | 14 Antioxidant/ | Dietary, lifestyle and medication | 0–3 | 0–60 |
| Lakkur et al., 2014b [ | 13 | 10 Antioxidant/ | Dietary, biomarkers, lifestyle and medication | 0–2 | 0–26 |
| Dash et al., 2015 [ | 16 | 10 Antioxidant/ | Dietary and lifestyle | −1–1 | −6–10 |
| Kong et al., 2015 [ | 14 | 10 Antioxidant/ | Dietary, lifestyle and medication | 0–2 | 0–28 |
| Annor et al., 2015 [ | 13 | 9 Antioxidant/ | Dietary, biomarkers, lifestyle and medication | 0–2 | 0–26 |
| Lakkur et al., 2015 [ | 14 | 10 Antioxidant/ | Dietary, lifestyle and medication | 0–2 | 0-–28 |
| Ilori et al., 2015 [ | 13 | 10 Antioxidant/ | Dietary and medication | 0–2 | 0–26 |
| Wang et al., 2017 [ | 15 | 9 Antioxidant/ | Dietary and lifestyle | 0–2 | 0–30 |
| Cho et al., 2017 [ | 8 | 3 Antioxidant/ | Dietary and lifestyle | 0–3 | 0–24 |
| Lee et al., 2017 [ | 7 | 4 Antioxidant/ | Dietary and lifestyle | 0–2 | 0–14 |
Lifestyle factors and medication components included in each a priori Oxidative Balance Score.
| Author (s), Year | Lifestyle Factors Components | Medication Components | |||
|---|---|---|---|---|---|
| Antioxidant | Pro-Oxidant | Antioxidant | |||
| Physical Activity | Smoking History | BMI | Aspirin | Other NSAID | |
| Van Hoydonck et al., 2002 [ | |||||
| Goodman et al., 2007 [ | X | X | X | ||
| Goodman et al., 2008 [ | X | X | X | ||
| Goodman et al., 2010 [ | X | X | X | ||
| Agalliu et al., 2011 [ | X | ||||
| Slattery et al., 2012 [ | X | X | |||
| Geybels et al., 2012 [ | X | ||||
| Dash et al., 2013 [ | X | X | X | ||
| Labadie et al., 2013 [ | X | X | X | ||
| Kong et al., 2014 [ | X | X | X | ||
| Slattery et al., 2014 [ | |||||
| Lakkur et al., 2014a [ | X | X | X | X | |
| Lakkur et al., 2014b [ | X | X | X | X | |
| Dash et al., 2015 [ | X | X | X | ||
| Kong et al., 2015 [ | X | X | X | ||
| Annor et al., 2015 [ | X | X | X | X | X |
| Lakkur et al., 2015 [ | X | X | X | ||
| Ilori et al., 2015 [ | X | X | |||
| Wang et al., 2017 [ | X | X | X a | ||
| Cho et al., 2017 [ | X | X | X | ||
| Lee et al., 2017 [ | X | X | |||
BMI: Body Mass Index; NSAID: Non-Steroidal Anti-Inflammatory Drug. a Obesity and waist: hip ratio.
Dietary components included in each a priori Oxidative Balance Score.
| Author (s), Year | Dietary Antioxidants a | Dietary Pro-Oxidants a | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | B9 | β-car | Lyco | β-cryp | Lute/Zeaxan | Retinol | D | E | Se | Zn | Ca | Fiber | Flav | GCS | Catechin | Fat | PUFAS | SFA | Fe | Alcohol | |
| Van Hoydonck et al., 2002 [ | X | X | X | ||||||||||||||||||
| Goodman et al., 2007 [ | X | X b | X | X | X c | X d | X e | X | X f | ||||||||||||
| Goodman et al., 2008 [ | X f | X f,g | X | X | X f | X e | X | X f | X | ||||||||||||
| Goodman et al., 2010 [ | X | X e | X | ||||||||||||||||||
| Agalliu et al., 2011 [ | X f | X f | X | X | X c | X f | X e | X | X f | X | |||||||||||
| Slattery et al., 2012 [ | X | X | X | X | X | X | X | X | X | X | X | ||||||||||
| Geybels et al., 2012 [ | X | X | X | X | X | X n | X | ||||||||||||||
| Dash et al., 2013 f [ | X | X g | X | X | X | X | X | X | X h | X | X | X | |||||||||
| Labadie et al., 2013 [ | X f | X f,i | X f | X f | X f | X | X | X | |||||||||||||
| Kong et al., 2014 [ | X f | X e | X | X | |||||||||||||||||
| Slattery et al., 2014 [ | X | X | X | X | X | X | |||||||||||||||
| Lakkur et al., 2014a [ | X f | X j | X | X | X | X f | X f | X | X | X | X | X | X f | X | |||||||
| Lakkur et al., 2014b [ | X | ||||||||||||||||||||
| Dash et al., 2015 f [ | X | X g | X | X | X | X | X e | X | X | X h | X | X | X | ||||||||
| Kong et al., 2015 [ | X f | X f,j | X f | x f | X f | X f,k | X | X | X f | X | |||||||||||
| Annor et al., 2015 [ | X | ||||||||||||||||||||
| Lakkur et al., 2015 f [ | X f | X j | X | X | X | X f | X f | X | X | X | |||||||||||
| Ilori et al., 2015 [ | X f | X j | X | X l | X | X f | X e | X | X f | X | |||||||||||
| Wang et al., 2017 f [ | X f | X g | X | X m | X f | X | X | X h | X | X f | X | ||||||||||
| Cho et al., 2017 [ | X | X | X | X | X | ||||||||||||||||
| Lee et al., 2017 [ | X | X g | X | X | X | ||||||||||||||||
Dietary components: C: vitamin C; β-car: β-carotene; lyco: lycopene; β-cryp: β-cryptoxanthin; lute/zeaxan: lutein/zeaxanthin; D: vitamin D; E: vitamin E; flav: flavonoids; GCS: glucosinolates; PUFAS: polyunsaturated fatty acids; SFA: Saturated Fatty Acids. a Questionnaire-based (Food Frequency Questionnaire) or 24-h recall dietary components considered. b α and β carotene intake for MAP study and plasma β carotene for MPC study. c Lutein/zeaxanthin for MAP study and only lutein intake for MPC study. d Total (α, β, γ and δ) tocopherol intake for MAP study and plasma α-tocopherol for MPC study. e Supplemental intakes. f Total intake = dietary intake and supplemental intake. g Includes total intake of plant-derived pro-vitamin A carotenes. h PUFAS-6 (pro-oxidant components) and PUFAS-3 (antioxidant components) as separate components. Lakkur et al., 2014a, omega-3 fatty acids. i Specifies the inclusion of carotenoids. j Includes α and β- carotene (dietary and supplemental intake) as separate components. k Specifies only α-tocopherols. l Total cryptoxanthin. m Only included lutein intake. n Heme iron intake.
Biomarkers and food components included in each a priori Oxidative Balance Score.
| Author (s), Year | Biomarker Components a | Food Components | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Antioxidant | Pro-Oxidant | Antioxidant | Pro-Oxidant | ||||||||
| α-carotene | β-carotene | Lycopene | Cryptoxanthin | Zeaxanthin | Lutein | α-tocopherol | γ-tocopherol | Ferritin | Crucifers | Red Meat | |
| Van Hoydonck et al., 2002 [ | |||||||||||
| Goodman et al., 2007 [ | X b | X c | |||||||||
| Goodman et al., 2008 [ | |||||||||||
| Goodman et al., 2010 [ | X | X | X | X d | X e | X | X | X | X f | ||
| Agalliu et al., 2011 [ | X | X | |||||||||
| Slattery et al., 2012 [ | |||||||||||
| Geybels et al., 2012 [ | |||||||||||
| Dash et al., 2013 [ | |||||||||||
| Labadie et al., 2013 [ | |||||||||||
| Kong et al., 2014 [ | X | X | X | X d | X | X | X | ||||
| Slattery et al., 2014 [ | |||||||||||
| Lakkur et al., 2014a [ | |||||||||||
| Lakkur et al., 2014b [ | X | X | X | X | X | X | X | X | |||
| Dash et al., 2015 [ | |||||||||||
| Kong et al., 2015 [ | |||||||||||
| Annor et al., 2015 [ | X | X | X | X | X | X | X | ||||
| Lakkur et al., 2015 [ | |||||||||||
| Ilori et al., 2015 [ | |||||||||||
| Wang et al., 2017 [ | |||||||||||
| Cho et al., 2017 [ | |||||||||||
| Lee et al., 2017 [ | |||||||||||
a Plasma- or serum-derived measurement. b Plasma β-carotene only was included in Oxidative Stress Score for prostate cancer in MPC study. c Plasma α-tocopherol only was included in Oxidative Stress Score for prostate cancer in MPC study. d Only included β-cryptoxanthin. e Zeaxanthin and lutein included in the same component. f For MPC study serum samples were no available and urinary selenium were available for MAP study.
Figure 1Components of the Oxidative Balance Scores (OBSs). Imbalance between the components in favor of a pro-oxidant state leads to OS and inflammation unless neutralized. ROS: Reactive Oxygen Species; RNS: Reactive Nitrogen Species; PUFAS: polyunsaturated fatty acids; NSAID: Non-Steroidal Anti-Inflammatory Drug; SFA: Saturated Fatty Acids.
Methodological criteria of the Oxidative Balance Scores.
| Author (s), Year | Cut-off Values | Scoring System for Each Component | Overall Score | Energy Adjustment and Other Methodological Issues | |
|---|---|---|---|---|---|
| Van Hoydonck et al., 2002 [ | Population-dependent | 3 population-dependent dietary components (based on tertiles of intake). | The intakes were scored from 1 to 3 for pro-oxidant factors and from 3 to 1 for antioxidant factors. High score group (a diet poor in antioxidant and rich in iron). | The overall score ranged between 3 and 9 points. | Questionnaire-based (24-h recall) dietary components were considered. |
| Goodman et al., 2007 [ | Predefined and population-dependent | 8 population-dependent dietary/biomarker components (based on median intakes); four predefined components for smoking (never, ever), Se supplements (yes, no), and medication (NSAID or aspirin use, non-use). | All dietary/biomarker components were divided into dichotomous categories based on the median value. For antioxidants, one point was awarded for high-level exposure and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 24 points. | Questionnaire and biomarker-based dietary components were considered. |
| Goodman et al., 2008 [ | Predefined and population-dependent | 7 population-dependent dietary components (based on sex-specific tertiles); five predefined components for smoking (never, former, current), Se supplements (yes, no), alcohol intake (low, moderate, heavy), and medication (NSAID or aspirin use, non-use). | All dietary components were divided into three categories based on the tertile values. For antioxidants, two points were awarded for high-level exposure, one point for intermediate, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 24 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Goodman et al., 2010 [ | Predefined and population-dependent | 10 population-dependent dietary/biomarker components (based on tertiles) and four predefined components for smoking (never, former, current), Se supplements (yes, no), and medication (NSAID or aspirin use, non-use). | All dietary/biomarker components divided into three categories based on the tertile values. For antioxidants, two points were awarded for high-level exposure, one point for intermediate, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 24 points. | Questionnaire and biomarker-based dietary components were considered. |
| Agalliu et al., 2011 [ | Population-dependent | 11 population-dependent dietary components (based on quintiles) and two population-dependent lifestyle components for smoking in pack-years and alcohol intake (in quartiles). | All dietary components were divided into five categories based on the quintile values. For antioxidants, four points were awarded for high-level exposure, one to three point for intermediate levels, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 52 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Slattery et al., 2012 [ | Predefined and population-dependent | 11 population-dependent dietary components (three categories for every component) and two predefined components for smoking (never, current smokers) and medication (NSAID use: never or recent/current use). | All dietary components were divided into three categories based on the tertile values. For antioxidants, two points were awarded for high-level exposure, one point for intermediate, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 26 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Geybels et al., 2012 [ | Predefined and population-dependent | 5 population-dependent dietary components (based on quartiles for every component) and two predefined components for smoking (never, current smokers) and alcohol (abstainers, and predefined levels of intake). | All dietary components were divided into four categories based on the quartile values. For antioxidants, two points were awarded for high-level exposure, one point for intermediate, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 26 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Dash et al., 2013 [ | Predefined and population-dependent | 11 population-dependent dietary components (two categories for every component) and four non-dietary components for smoking, alcohol intake, obesity and physical activity. | Four methods were used of weighting all components: OBS-equal weight, OBS-lit review, OBS- | Transformed variables were multiplied by their weights and summed to generate the overall OBS. | Questionnaire-based (FFQ) dietary components were considered. |
| Labadie et al., 2013 [ | Predefined and population-dependent | 7 population-dependent dietary components (based on sex-specific tertiles) and four predefined components for smoking (never, former, current), alcohol intake (low, moderate and heavy), and medication (NSAID or aspirin use, non-use). | All dietary components were divided into three categories based on the tertile values. For antioxidants, two points were awarded for high-level exposure, one point for intermediate, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 22 points. | Questionnaire-based dietary components were considered. Dietary components were adjusted for total energy intake. |
| Kong et al., 2014 [ | Predefined and population-dependent | 9 population-dependent dietary/biomarkers components (tertiles for every component) and five predefined components for smoking (never, former, current), Se supplements (yes, no), alcohol intake (low, moderate, heavy), and medication (NSAID or aspirin use, non-use). | All dietary/biomarker components were divided into three categories based on the tertile values. For antioxidants, two points were awarded for high-level exposure, one point for intermediate, and 0 for low-level exposure. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 28 points. | Questionnaire and biomarker-based dietary components were considered. |
| Slattery et al., 2014 [ | Population-dependent | 6 population-dependent dietary components (quartiles for every component) including alcohol. | All dietary components were divided into four categories based on the quartile values. For antioxidants, two points were awarded for high-level exposure (4th quartile), one point for intermediate levels, and 0 for low-level exposure (1st quartile). The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 12 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Lakkur et al., 2014a [ | Predefined and population-dependent | 15 population-dependent dietary components (quartiles); five predefined components for smoking (never, former, current), alcohol, BMI (normal, overweight, obese), physical activity and medication (NSAID use, non-use). | All dietary components were divided into four categories based on the quartile values. For antioxidants, two points were awarded for high-level exposure (4th quartile), one point for intermediate levels, and 0 for low-level exposure (1st quartile). The score was reversed for pro-oxidant components. Two weighting methods were applied: equal weights and literature-based weights. | The overall score ranged between 0 and 60 points. The score was divided into tertiles intervals or quartiles: low (scores 4–11, 5–10 and 4–12), intermediate (score 12–14, 11–15 and 13–15), and highest antioxidant group (score 15–22, 16–21 and 16–23). | Questionnaire-based (FFQ) dietary components were considered. |
| Lakkur et al., 2014b [ | Predefined and population-dependent | 8 population-dependent dietary/biomarkers components (tertiles) and one population-dependent lifestyle factors (physical activity in tertiles) and four predefined components for smoking (non-smokers and smokers), alcohol intake (non-drinkers and drinkers), and aspirin or NSAID medication (use, non-use). | All dietary/biomarker components were divided into three tertile values. For antioxidant components: two points were awarded for high-level exposure, one point for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 23 points. | Biomarker-based and dietary (FFQ) components were considered. |
| Dash et al., 2015 [ | Predefined and population-dependent | 11 population-dependent dietary components (two categories for every component) and four non-dietary components for smoking, alcohol intake, obesity and physical activity. | Four methods were used of weighting all components: OBS-equal weight, OBS-lit review, OBS- | All components were multiplied by their weights and summed to generate the overall OBS. | Questionnaire-based (FFQ) dietary components were considered. |
| Kong et al., 2015 [ | Predefined and population-dependent | 10 population-dependent dietary components (sex-specific tertiles for every component) and four predefined components for smoking (never, former, current), alcohol consumption (non-drinkers, moderate and heavy drinkers), and NSAID medication (use, non-use). | All dietary components were divided into three tertile values. For antioxidant components: two points were awarded for high-level exposure, one point for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall OBS ranged between 0 and 28 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Annor et al., 2015 [ | Predefined and population-dependent | 7 population-dependent dietary/biomarkers components (tertiles); one population-dependent lifestyle factors (physical activity tertiles) and five predefined components for smoking (non-smokers, current smokers), alcohol intake (non-drinkers, drinkers), and aspirin or NSAID medication (use, non-use), and BMI (normal, overweight and obese). | All dietary/biomarker components were divided into three tertile values. For antioxidant components: two points were awarded for high-level exposure, one point for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 26 points. | Biomarker-based and dietary components were considered. |
| Lakkur et al., 2015 [ | Predefined and population-dependent | 10 population-dependent dietary components (tertiles) and four predefined components for smoking (non-smokers and current smokers), alcohol intake (non-drinkers, moderate, heavier drinkers), and aspirin or NSAID medication (use, non-use). | All dietary components were divided into three tertile values. For antioxidant components: two points for high-level exposure, one point for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall score ranged between 0 and 28 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Llori et al., 2015 [ | Predefined and population-dependent | 10 population-dependent components (sex-specific tertiles for every component) and three predefined components for alcohol (non-drinkers, moderate, heavy drinkers) and aspirin/NSAID medication (use, non-use). | All dietary components were divided into three tertile values. For antioxidant components: two points were awarded for high-level exposure, one point for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall OBS ranged between 0 and 26 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Wang et al., 2017 [ | Predefined and population-dependent | Similar OBS components as Dash et al., 2013 [ | The OBS was built using the weighted method as described by Dash et al., 2013 [ | The overall OBS ranged between 0 and 30 points. | Questionnaire-based (FFQ) dietary components were considered. |
| Cho et al., 2017 [ | Predefined and population-dependent | 6 population-dependent components (sex-specific quartiles), including four dietary and two non-dietary components (BMI and physical activity), and two non-dietary predefined components for smoking (never, former, current), and alcohol (levels of intake). | For antioxidant components: three points were awarded for high-level exposure, one or two points for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall OBS ranged between 0 and 24 points. | Questionnaire-based (24-h recall) dietary components were considered. |
| Lee et al., 2017 [ | Predefined and population-dependent | 5 population-dependent components including four dietary components and one lifestyle factor (tertiles) and two predefined components for smoking (never, former, current) and alcohol intake (levels of alcohol intake). | For antioxidant components: three points were awarded for high-level exposure, one or two points for intermediate, and 0 for low predominance of antioxidants. The score was reversed for pro-oxidant components. | The overall OBS ranged between 0 and 14 points. | Questionnaire-based (24-h recall) dietary components were considered. |
BMI: Body Mass Index; CKD: Chronic Kidney Disease; CPS-II: Cancer Prevention Study II; FFQ: Frequency Food Questionnaire; FIP: F2-isoprostanes; FOP: Fluorescent Oxidative Products; MAP study: Markers of Adenomatous Polyps study; MetS: metabolic syndrome; MPC study; Markers of Prostate Cancer study; mtDNA: mitochondrial DNA copy number; NSAID: Non-Steroidal Anti-Inflammatory Drug; OBS: Oxidative Balance Score. Higher OBS values reflect a predominance of antioxidant exposure in almost all OBSs.
Rationale for the inclusion of some components in a priori OBS in relation to OS.
| Dietary, Biomarkers, Food, Lifestyle Factors, and Medication Components | |
|---|---|
| Antioxidants | |
| Antioxidant that scavenges ROS and RNS | |
| Deactivators of singlet oxygen and lipid peroxidation | |
| Lipophilic antioxidant, suppressor of the oxidative damage of polyunsaturated fatty acids present in lipoproteins, biological membranes, and tissues, through the elimination of free radicals such as the radical peroxide | |
| Donation of hydrogen to free radicals | |
| Sensitive to induction of electrophiles such as omega-3 PUFAs and hemoxygenase-1, which catalyzes heme to biliverdin and the induction of glutathione peroxidase | |
| Cofactors of enzymes involved in the endogenous antioxidant system that interrupt cellular oxidative processes | |
| Prooxidants | |
|
| Intake of lipids can contribute to oxidative stress through lipid peroxidation |
| Increase the formation of lipid peroxides that contribute to oxidative stress | |
| Oxidative DNA damage | |
| Association with oxygen transport; can catalyze oxidative reactions in the formation of free radicals | |
| Possible intensification of oxidative stress mediated by iron intake contained in red meat | |
|
| |
| Antioxidants | |
| Increase in the adaptive response to oxidative stress by activating the cellular antioxidant signaling systems and improving the expression of antioxidant enzymes | |
| Prooxidants | |
| Possible increase in ROS generation and increase of inflammatory processes | |
| Exogenous prooxidant: increased oxidative stress and oxidative imbalance in cellular tissues | |
| Related to increased ROS markers | |
|
| |
| Antioxidants | |
| Inhibition of ROS production in human endothelial cells exposed to oxidized LDL-cholesterol | |
| Regulation of ROS and RNS to reduce inflammation and cell damage | |
BMI: Body Mass Index; DNA: Deoxyribonucleic acid; NSAID: Non-Steroidal Anti-Inflammatories; LDL-cholesterol: Low-density lipoproteins-Cholesterol; OS: Oxidative Stress; PUFA: Polyunsaturated fatty acids; ROS: Reactive Oxygen Species; RNS: Reactive Nitrogen Species; SFA: Saturated Fatty Acids.
Main characteristics of studies analyzing the association between a priori Oxidative Balance Scores and health outcomes.
| Author (s), Year | Country, Population ( | Study, Design, | Main Outcome | Covariables in Adjusted Model | OR/RR/HR (95 % CI) a, Multivariable Adjusted |
|---|---|---|---|---|---|
| Van Hoydonck et al., 2002 [ | Belgium | BIRNH study | All-cause mortality | Age, educational level, BMI, total energy intake and smoking (pack-years) | RR for high vs. low OBS: |
| Goodman et al., 2007 [ | USA | MAP and MPC studies | Adenomatous polyps | Age, sex, race, energy intake | MAP study (adenomas) |
| Goodman et al., 2008 [ | USA | Minnesota Digestive Healthcare | Colorectal adenomas | Age, sex, hormone therapy, race, education, family history of colorectal cancer, energy intake, BMI, alcohol consumption, calcium, vitamin D, folic acid, red meat, multivitamin and dietary fiber | OR for high vs. low OBS |
| Goodman et al., 2010 [ | USA | MAP and MCP studies | Colorectal adenomas | Age, race, total energy intake, blood cholesterol, BMI, and family history of prostate cancer or colorectal cancer | OBS (continuous, per unit increment) OR = 0.90 (0.83, 0.97) in both studies |
| Agalliu et al., 2011 [ | Canada | CSDLH study | Prostate cancer | Age, race, BMI, physicalactivity, and education | No association |
| Slattery et al., 2012 [ | Utah, USA | Case-control study | Colon cancer | Total energy intake in analyses with dietary variables | OR high vs. low OBS: |
| Geybels et al., 2012 [ | The Netherlands | NLCS study | Prostate cancer | Age, smoking intensity and duration | HR for high vs. low OBS: 1.16 (95% CI: 0.98–1.37) |
| Dash et al., 2013 [ | USA | CPRU study, MAP I study, MAP study | Colorectal adenomas | Age, sex, education, family history of colorectal cancer, aspirin, nonsteroidal anti-inflammatory, calcium, vitamin D, folate, fiber, energy intake, cumulative estrogen exposure, excluding oral contraceptive use and use of menopausal hormone therapy | OR for high vs. low OBS ranged from 0.38–0.54 for the 4 OBS (all were statically significant). |
| Labadie et al., 2013 [ | USA | CPRU study; MAP I study, MAP II study | Colorectal adenomas by | Age, sex, hormone therapy, family history of colorectal cancer, body composition, energy intake, physical activity, calcium, fiber, red meat, vitamin D (dietary + supplemental) | The OBS was not associated with colorectal adenoma risk by the genetic polymorphisms, individually or in combined gene scores |
| Kong et al., 2014 [ | USA | MAP I | Colorectal adenoma | Age, race, sex, BMI d, energy intake, plasma cholesterol, family history of colorectal cancer, hormone replacement therapy, fiber, physical activity, study (MAP I or MAP II) | OR for high vs. low OBS = 0.39 (0.17–0.89) |
| Slattery et al., 2014 [ | USA | Breast Cancer Health Disparities study | Breast cancer | Age, study center, BMI in referent year, parity, genetic admixture | OR for high vs. low OBS = 0.74 (0.64–0.84) |
| Lakkur et al., 2014a [ | USA | CP Study II Nutrition Cohort | Prostate cancer | Age, energy intake, calcium, vitamin D and folate intake, race, education, family history of prostate cancer, cholesterol lowering drug use, finasteride use, history of prostate cancer screening | HR for high vs. low OBS: |
| Lakkur et al., 2014b [ | USA | SRSH study | FIP, FOP, mtDNA | Age, sex, BMI, and race/origin | Negative association with FIP (OR high vs. low OBS = 0.04; 95% CI: 0.01–0.17) but positive with FOP (OR high vs. low OBS = 5.64; 95% CI: 2.35–13.54). |
| Dash et al., 2015 [ | USA | CP Study II Nutrition | Colorectal cancer | Age, sex, education, family history of colorectal cancer in a first-degree relative, colorectal cancer screening, nonsteroidal anti-inflammatory, calcium, vitamin D, energy intake, and hormone replacement therapy | RR for high vs. low quartile: |
| Kong et al., 2015 [ | USA | REGARDs study | All-cause mortality | Age, sex, race, SES, region, BMI, energy intake, and physical activity | HR for high vs. low OBS: |
| Annor et al., 2015 [ | USA | SRSH study | Hypertension | Age, sex, education, and race/origin | OR for high vs. low OBS = 0.17 (0.79–0.96) |
| Lakkur et al., 2015 [ | USA | REGARDs study | CRP | Age, sex, energy intake, BMI, race, educational level, region, and physical activity | OR for high vs. low OBS: |
| Ilori et al., 2015 [ | USA | REGARDs study | ESRD | Age, sex, race, region and calories, BMI, smoking, waist circumference, physical activity, education, income, SBP, DBP, total cholesterol, CAD, diabetes and statin medications | OR/HR for high vs. low OBS: |
| Wang et al., 2017 [ | USA | CPRU, MAP I, MAP II | Interaction between based excision repair genes (BER) in genetic scores and OBS with colorectal adenoma risk | Age, sex, family history of colorectal cancer in a first degree relative, NSAID use, energy intake, fiber, circulating 25-OH-vitamin D3 concentration | OR for high weighted BER score and low OBS = 2.19 (1.19–3.99); OR for low weighted BER score and low OBS = 1.07 (0.61–1.93); OR for high weighted BER score and high OBS = 1.38 (0.75–2.53) |
| Cho et al., 2017 [ | Korea | KNHANES-V study | GGT | Age, energy intake, fasting plasma glucose, total cholesterol, SBP, and alanine aminotransferase | OR for high vs. low OBS = 0.05 (0.01–0.19) for men and 0.27 (0.09–0.78) for women ( |
| Lee et al., 2017 [ | Korea | KARE cohort study | MetS | Age, geographic area, sex, and BMI | OR for high vs. low OBS: |
Antioxidant genes: SOD2 (superoxide dismutase), CAT, GSTP1; BER GRS: Base Excision Repair Genetic Risk Scores; Biomarkers: CRP, FIP, FOP: C-Reactive Protein, F2-isoprostanes, Fluorescent Oxidative Products; BIRNH study: Belgian Interuniversity Research on Nutrition and Health study; BMI: Body Mass Index; CAD: Coronary Artery Disease; Cholesterol: HDL (high density lipoproteins), LDL (low density lipoproteins); CKD: Chronic Kidney Disease; CPRU study: Cancer Prevention Research Unit. CP study II Nutrition Cohort: Cancer Prevention Study II Nutrition Cohort; CSDLH study: Canadian Study of Diet, Lifestyle and Health cohort; CVD: cardiovascular disease; DBP: Diastolic Blood Pressure; ESRD: End Stage Renal Disease; EPX rs2302313: eosinophil peroxidase; GGT: γ-glutamyltransferase; KARE study: Korea Association Resource study; KNHANES-V study: Korea National Health and Nutrition Examination survey; KPMCP: Kaiser Permanente Care Program of Northern California; GRS: Genetic Risk Scores; MAP study: Markers of Adenomatous Polyps study; MetS: Metabolic syndrome; MPC study: Markers of Prostate Cancer study; MPO rs2243828: myeloperoxidase; NA ancestry: Native American ancestry; NLCS study: Netherlands cohort study; NOS2A: nitric oxide synthase; NSAID: nonsteroidal anti-inflammatory drug; OBS: Oxidative Balance Score; OSS: Oxidative Stress Score; SBP: systolic blood pressure; SEER summary stage: Surveillance Epidemiology and End Results; SES: Socioeconomic status; SRSH study: Study of Race, Stress, and Hypertension; REGARDs study: Reasons for Geographic and Racial Difference in stroke study; USA: United States; WBC count: waist B circumference count. a OR: Odds Ratio, RR: relative risk and HR: hazard ratio was calculated compared the lowest OBS category vs. the highest OBS category (categories defined as tertiles, quartiles or quintiles).